Cite
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.
MLA
Surial, Bernard, et al. “Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.” Clinical Infectious Diseases, vol. 77, no. 5, Sept. 2023, pp. 729–37. EBSCOhost, https://doi.org/10.1093/cid/ciad286.
APA
Surial, B., Chammartin, F., Damas, J., Calmy, A., Haerry, D., Stöckle, M., Schmid, P., Bernasconi, E., Fux, C. A., Tarr, P. E., Günthard, H. F., Wandeler, G., Rauch, A., & Study, the S. H. C. (2023). Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy. Clinical Infectious Diseases, 77(5), 729–737. https://doi.org/10.1093/cid/ciad286
Chicago
Surial, Bernard, Frédérique Chammartin, José Damas, Alexandra Calmy, David Haerry, Marcel Stöckle, Patrick Schmid, et al. 2023. “Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.” Clinical Infectious Diseases 77 (5): 729–37. doi:10.1093/cid/ciad286.